ed grants of $1 million or more to the following members of the Robert Wood Johnson Medical School faculty: a four-year, $1,257,900 competing continu- ation grant for "Functional Analysis of SBP2 and Selenocysteine Incorporation" (2R01GM077073). three-year, $1,954,578 grant for "PCMH Implementation Strategies: Implications for Cancer Survivor Care" (1R01CA176545). Biology, a five-year, $1,739,065 grant for "The Role of Neurotrophins in Oligodendro- cyte Function" (R01NS036647). year, $1,247,768 competing continuation grant for "The Regulation of Cell Metabolism and Proliferation by MTOR Complex 2" (2R01GM079176). year, $1,532,404 competing continuation grant for "Regulators of Translation Elongation Factor EEF1A" (2R01GM057483). for Advanced Biotechnology and Medicine, a four-year, $2,544,000 award for "Rutgers Mass Spectrometry Center for Integrative Neuroscience Research" (P30 NS046593). Dr. Lobel was a dual recipient of the award with Hong Li, PhD, associate professor of microbi- ology, biochemistry, and molecular genetics and director, Center for Advanced Proteomics Research, New Jersey Medical School. physician-scientists have been appointed to Wood Johnson Medical School. Department of Medicine, and ior associate dean for clinical and translational research. Dr. Wondisford and Dr. Radovick are both Chancellor Scholars, a designation awarded by the Rutgers Biomedical and Health Sciences to the school's academi- cally strongest new recruits. pediatrics, and physiology and as director of the division of metabolism at Johns Hopkins School of Medicine. He also served as director of the Johns Hopkins Diabetes Institute, by research scientists and physi- cians to improve the quality of care for patients. His well- funded research program focuses on pituitary and pancreatic hormonal growth and regula- tion. He is the inventor of an approach to synthesize recombi- nant human thyroid-stimulating hormone (TSH), for which he synthetic TSH, Thyrogen, is approved by the U.S. Food and Drug Administration for use in the diagnosis and treatment of patients with thyroid cancer. Pediatrics, director of the divi- sion of endocrinology, and vice chair for research, Department of Pediatrics, at Johns Hopkins School of Medicine. An expert in pedi- atric growth and devel- opment disorders, research program focusing on steroids that control sexual maturity and reproduction, neurotransmitters, and growth factors. In addition, she studies the deficiency of hormones pro- duced by the pituitary gland in children with growth failure. the Association of American Physicians and the American Society for Clinical Investigation. Join Faculty |